1 report

  • Deal Rationale
  • Synergy Pharma Completes Public Offering Of Shares For US$90 Million

Synergy Pharmaceuticals Inc (Synergy Pharma) develops therapies for gastrointestinal (GI) diseases.

  • Gastrointestinal Drug
  • Pharmaceutical
  • United States
  • Corporate Finance
  • Synergy Pharmaceuticals, Inc.